1. Day C, Gray A. Health and Related Indicators. (In Ntuli, A, Suleman, F, Barron, P, McCoy, D., eds). South African health review. Durban: Health system trust; 2001. p. 283–340.
2. Lloyd-Sherlock P, Beard J, Minicuci N, Ebrahim S, Chatterji S. Hypertension among older adults in low-and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014;43(1):116–128.
3. Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function. Am J Phys Heart Circ Phys. 2005;289(6):H2281–90.
4. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol. 2003;35(6):881–900.
5. Navar LG, Harrison-Bernard LM, Imig JD, Wang C-T, Cervenka L, Mitchell KD. Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade. J Am Soc Nephrol. 1999;10:S266–72.